CNN features SAB Biotherapeutics
May 15, 2020
The COVID-19 therapeutic being developed by Sioux Falls-based SAB Biotherapeutics has been featured in a CNN report.
The piece included an interview with CEO Eddie Sullivan, who confirmed trials are still on track to start in humans early this summer. If all goes well, a therapeutic could be on the market early next year, he said.
Jodi’s Journal: The little biotech company that could beat COVID-19
